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Mutations in the RASA-1 gene underlie several related disorders of vasculogenesis. Capillary malformation-arteriovenous
malformation (CM-AVM) is one such entity and was recently encountered in a neonate who demonstrated its clinical
and radiologic features. A single mutation in the RASA-1 gene was detected.
A novel flow reduction strategy was employed to a large AVM affecting the patient’s upper limb. The imaging findings,
surgical procedure and patient’s improved post-operative state are described.
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RASA-1 gene mutations present with a variety of clinical
phenotypes. Parkes-Weber syndrome (PKWS) and the
more recently described capillary malformation - arterio-
venous malformation syndrome (CM-AVM) are two such
entities. The hallmarks of both PKWS and CM-AVM are
the presence of fast-flow vascular malformations and capil-
lary malformations (CM). A “fast-flow” vascular malforma-
tion is defined as a lesion containing abnormal fistulous
connections between arteries and veins, without an inter-
vening capillary bed. This includes both arteriovenous mal-
formations (AVM) and arterio-venous fistula (AVF).
Capillary malformations are present in 0.3% of neonates,
and appear as a characteristic pink macular stain, often
described as a "port wine stain" [1]. Histologically, the le-
sion is characterized by wide caliber or increased number
of dermal capillaries [2]. Although CMs are usually iso-
lated, they may arise in the setting of a syndrome, such as
Klippel-Trenaunay, Sturge-Weber, or Proteus. If capillary
malformations are associated with a syndrome that incor-
porates a high-flow lesion such as PKWS or CM-AVM,
high output heart failure may ensue. In these instances,* Correspondence: ggb5@columbia.edu
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reproduction in any medium, provided the ormost commonly only the CM is evident at birth, and the
AVM or AVF presents later in childhood.
In this report, we present a neonate diagnosed at birth
with a large upper extremity capillary malformation and a
clinically apparent fast-flow vascular malformation with
limb enlargement, in the context of a strong family history
of vascular malformations and highlight the radiologic
characteristics.Case presentation
The patient was born at an outside hospital at 41 weeks
gestation via spontaneous vaginal delivery to a 20 year-old
G2P2. Birth weight was 3991 g and head circumference
was 36 cm (both values above the 95 percentile). The
pregnancy and delivery were reportedly without complica-
tion. The infant was transferred to our institution on the
fourth day of life for further management of a vascular
skin lesion and upper extremity enlargement and edema.
Upon questioning, there was a family history of vascular
birthmarks. The patient's mother has several pink macules
on her trunk and extremities. An older sibling also exhib-
ited a port wine stain.
The neonate was hemodynamically stable. On physical
examination, there were blanching salmon-colored
macules, extending over the left cheek, left ear, chin and
across the left neck (Figure 1). There were darker, pink/
violaceous lesions over the left temporal and occipital
scalp. A pink patch extended over most of the right upperd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 First day of life: There is a macular rash extending from
the left neck, across the chest and involving the right upper
extremity which is larger than the left upper extremity. A
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violaceous. The entire right upper extremity was enlarged
and tensely edematous. The right arm measured 17 cm in
length, 1 cm longer than the right, and the right lower
arm circumference measured 14.5 cm, 3.5 cm greater than
the left. Axillary, brachial, and radial pulses were bound-
ing. At the initial and subsequent examinations, the baby
was noted to move the right arm only minimally as com-
pared with the left. The remainder of the physical examin-
ation was unremarkable.
There was no laboratory evidence of coagulopathy or
platelet consumption.H
C
Figure 2 Ultrasound: 2A) Doppler waveform obtained from the
right brachial artery reveals absence of an expected transient
reversal of flow (arrow). Also seen is massive dilation of the brachial
artery (calipers in artery). 2B) Dilated vessels (arrows) are seen
coursing through the abnormally hyperechoic, poorly defined and
enlarged musculature. Humerus (H). 2C) Normal left arm for
comparison.Imaging studies
Prenatal screening ultrasound was reportedly normal.
An echocardiogram performed at the referring institu-
tion on the first day of life was also reportedly normal.
Ultrasound performed on the fourth day of life revealed
massive dilation of the right subclavian, axillary and bra-
chial artery (Figure 2A) as well as a dilated deep venous
system. The diameter of the brachial artery was 5 mm.
Spectral Doppler analysis of the affected arteries demon-
strated a low resistance waveform (Figure 2A). There
was arterialization of the waveforms obtained from the
adjacent draining veins. There was increased vascularity
of the forearm. Additionally, the musculature appeared
homogeneously hyperechoic; however, there was no
discrete mass (Figure 2B).
An MRI of the right upper extremity and chest
obtained on the seventh day revealed the aneurysmal
vessels, extending from the origin of the right subclavian
artery to the right brachial artery. Time-resolved post
contrast magnetic resonance angiography (TRICKS,
General Electric) showed near-simultaneous enhance-
ment of the right upper extremity arteries and draining
dilated veins (Figure 3A). There was abnormally high T2
signal in the musculature, though no mass was identified(Figure 3B). An MRI brain scan and a chest radiograph
were both normal.
A postnatal echocardiogram was interpreted as mild
right ventricular hypertrophy with normal biventricular
function. The superior vena cava return to the right
atrium appeared increased, consistent with increased
flow. The right subclavian artery was markedly dilated.
Taken together, these are consistent with high-grade
arteriovenous shunting in the right arm, with resultant




Figure 3 MRI 3A) Time-resolved MR angiogram shows near
simultaneous opacification of a markedly dilated right upper
extremity artery (arrow) and vein (curved arrows). 3B) T2
weighted axial sequence shows increased signal and enlargement of
right upper extremity soft tissues (arrow) and large vascular flow
voids (curved arrow). 3C) T1 fat saturated post-gadolinium axial
sequence suggests enhancement of the musculature in the right
forearm (arrow) compared with the left forearm.
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Sequencing of the RASA-1 coding region revealed a
single mutation (c.2603 + 1 G > A one copy).
Management
The Columbia University Vascular Anomalies Group was
consulted. Due to the appearance of the swollen arm, and
the dramatic imaging findings, the patient was considered
to be at risk for heart failure, vascular "steal" phenomenon,
bleeding, ulceration, and loss of arm function or amputa-
tion. After multidisciplinary review, a recommendation
was made to limit flow to the malformation, but to pre-
serve future access for any potential endovascular proce-
dures, by surgically banding the right subclavian artery atits origin - a novel approach for treatment of such a lesion.
The patient’s family elected to proceed.
Details of procedure
Briefly, via a median sternotomy, the pericardium was
opened and a large chylous pericardial effusion was
noted (triglyceride level of 1718 mg/dl). The innominate,
right subclavian and right carotid arteries were exposed,
taking care to protect the recurrent laryngeal nerves. A
Goretex tube was passed around the proximal right
subclavian artery and closed, making a band around
the subclavian artery with a 3 mm lumen (Figure 4). The
patient tolerated the procedure well and remained
hemodynamically stable throughout.
Follow-up
Immediately following the procedure, there was signifi-
cant improvement in the appearance of the right arm, a
finding which is maintained at six months (Figure 5).
The skin lesions appeared to lighten, and the soft tissue
edema progressively decreased. The patient began to
use her arm, with progressive improvement. Repeat
ultrasound with Doppler reflects this clinical progress,
showing a trend toward decreasingly plethoric vessels
and decreased edema in the soft tissues. Interestingly,
the brachial artery diameter has remained unchanged
(5 mm). Echocardiograms demonstrated mild and bor-
derline right ventricular hypertrophy at one and two
months postoperatively, respectively.
Discussion
The RASA-1 gene (RAS p21 protein activator 1; OMIM
139150) located on chromosome 5q13.3 encodes the
protein p120 RasGAP, a negative regulator of the Ras
p21 oncogene. Mouse embryos with targeted disruptions
in rasGAP fail to transform their initial aggregation of
endothelial cells into a functioning vascular network
[3,4]. The RASA-1 related syndromes are inherited as an
autosomal dominant trait with a penetrance estimated
between 89-96% [5-7].
Several families with varying inactivating mutations in
the RASA-1 gene have been studied [5,6,8-12]. The
phenotypic hallmark of the RASA-1 malformation appears
to be the presence of multifocal capillary malformations
however fast-flow vascular malformations are seen in
more than one third of affected individuals. Capillary mal-
formations in this syndrome often have a pale halo around
the pink or red macular stains which is atypical for a spor-
adic CM [13]. The location of the associated fast-flow vas-
cular malformations is variable. These may be identified in
the intracranial space, such as a vein of Galen malforma-
tion, intradurally, or in extracranial locations, such as the
face, trunk, or extremities. Visceral AVMs are not typically
seen. Some patients with a RASA-1 mutation present with
Figure 4 Illustration of the surgical banding. Note the massive dilation of the right subclavian artery (arrow) compared with left (curved
arrow). The right subclavian diameter was reduced after the banding (*).
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flow vascular anomalies, including extensive intramuscular
microfistula, capillary malformations, and limb over-
growth. Previously thought to be a sporadic condition, its
shared genetic basis with CM-AVM suggests that the two
entities are merely different manifestations of the same
genetic entity. Mutations in the RASA-1 gene also under-
lie at least some cases of vein of Galen malformation [6].
In addition, there is evidence of defective lymphangiogen-
esis [14] although this is generally clinically unapparent.Figure 5 Six months of life: The right arm is less asymmetrically
enlarged and the macular rash is less intense. The patient now
demonstrates function of the upper extremity.The localized nature of the vascular lesions and their
multifocality are intriguing in the setting of a disease caused
by a germ line mutation. Some authors have invoked a
somatic “second hit” mechanism to explain the large areas
of unaffected tissues. Indeed, such a mechanism is reported
to underlie several genetic vascular anomalies, such as glo-
muvenous malformation, cerebral cavernous malformation,
and the PTEN mutation syndromes. Of further interest are
the variable phenotypes appearing within each affected
family. Our patient, for example, has a strong family history
of multiple capillary malformations but without AVM or
AVF. It is possible that such lesions are present and have
been clinically silent, as the family members have not
undergone imaging screening. However, previous work
involving screened family members who carry identical
mutations have documented phenotypic variability, with
many genetically affected family members entirely lacking a
high-flow vascular lesion. For example, this patient’s genetic
alteration in the (c.2603 + 1 G >A) is identical to a patient
reported by Revencu [6], et al. That patient manifested
CM’s without fast-flow vascular anomalies but also was
reported to have chylous ascites.
To our knowledge, this case represents the youngest
reported patient diagnosed with CM-AVM and high-
lights the importance of early clinical detection. The
presence of multiple capillary malformations should
raise suspicion of a syndrome with mixed vascular
anomalies. The family history and physical examination
may offer important clues. Complete assessment and the
broader differential diagnosis are beyond the scope of
this article; however, evidence for an underlying fast-
flow lesion should be sought on physical exam. This
includes local warmth, palpable thrill, or an audible
bruit. Any limb enlargement should be noted.
Imaging workup generally begins with ultrasound and
Doppler. This case demonstrates the classic features of a
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finable mass on gray-scale ultrasound. Large, macroscopic
anechoic vessels are present. There is an abnormally low
resistive pattern on the spectral tracings in the feeding ar-
tery and increased pulsatility in the draining veins. We
also detected a plethora of vessels, completing the assess-
ment of an AVM. The MRI corroborated these findings.
Of interest, the ultrasound revealed abnormal echotex-
ture and the MRI demonstrated abnormal signal within
the distal musculature. Although regional edema might
explain such a finding, we suspect rather that this repre-
sents numerous microfistulae in the musculature that are
too small to resolve with our imaging technique. In sup-
port of this interpretation is the mild general enhancement
of the involved muscles noted after gadolinium adminis-
tration (Figure 3C). This underscores the overlap with
PKWS. The above findings, in the context of the clinical
history should strongly suggest a RASA-1 mutation.
When a significant fast-flow vascular lesion is present,
a cardiac echo should also be obtained to exclude high
output heart failure.
Conclusion
We have presented what we believe to be the youngest
patient to date to be diagnosed with CM-AVM syn-
drome. This case highlights the importance of searching
for associated lesions in the presence of multifocal CM’s.
When fast-flow vascular components are present, treat-
ment can be initiated early to avoid future morbidity. A
working knowledge of associated syndromes, a multidis-
ciplinary approach and appropriate imaging studies and
their interpretation can yield a timely diagnosis.
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